Sales and Marketing

Takeda has unveiled new Phase 3 data for its oral proteasome inhibitor Ninlaro (ixazomib) in the treatment of newly diagnosed …

Data science firm Genomics Plc, which lays claim to “the world’s largest genomic database”, has welcomed Mitchell Harris to the …

The FDA has green-lit Boehringer Ingelheim’s multi-targeted tyrosine kinase inhibitor Ofev (nintedanib) in the treatment of chronic fibrosing interstitial lung …

Andreas Johannesson has been announced as Alligator Bioscience’s new interim Chief Financial Officer (CFO), replacing ex-CFO Per-Olof Schrewelius who it …

Nordic Nanovector has appointed Dr Lars Nieba as the interim Chief Executive Officer. He is currently the company’s Chief Technology …

Neuronetics, Inc and Chris Thatcher, the President and CEO, have mutually agreed that he will step down from his positions …

Pharmacovigilance is a critical function in ensuring public health, but is our current system built to tackle the challenges of …

The British Government has outlined its emergency legislation to tackle coronavirus in which people could leave work to become volunteers …

The FDA has moved to approve its first therapy to directly treat the overproduction of the hormone cortisol which is …

Eli Lilly is asking some of its employees to work from home to stop the spread of coronavirus on its …

Uganda is preparing to enter the final stages of developing a new HIV treatment to reduce stigma and discrimination of …

NICE, the NHS’ drug watchdog in England and Wales, has announced its decision not to recommend Sanofi and Regeneron’s IL-4 …

The coronavirus continues to threaten the global drug supply line, with disruption to the US drug production pipeline from the …

New research has pinned a concrete figure on the perennial industry question: how much does it cost to bring a …

China has moved to authorise Roche’s Actemra (tocilizumab) as a treatment for severe complications from contracting the COVID-19 coronavirus in …